December 11, 2017
In recent weeks, pharma plays like Valeant Pharmaceuticals Intl (VRX) and Teva Pharmaceutical Industries (TEVA) have surged. Valeant is up almost 100% since October and Teva is up almost 50%. In other words, pharma has become a hot sector as Trump’s corporate tax cuts near finalization. One pharma stock that is lagging but has a gorgeous bull flag is Endo International (NASDAQ:ENDP). I have placed this one on my watch list. Should the bull flag start to breakout with price pushing over $7.75, it becomes a strong buy with major upside potential. The upside potential target is $10.65. This would be a catch-up trade to the other pharma plays like Valeant and Teva.
December 7, 2017
Today, leading computer networking company, Ciena Corp (NYSE:CIEN), is tanking after reporting earnings. The stock is falling lower by nearly 5.0 percent to $20.24 a share. CIEN stock is now trading below its 50-day moving average, this puts the stock in a weak technical position. The monthly chart is now signaling further downside for the stock. Traders must now look at the $16.75 area as the next major chart support level. Very often, when a stock declines so sharply in a single trading day it will take time before it will be defended by the institutional money crowd. I will be keeping this stock on my watch list until the equity drops into this important support level.
December 6, 2017
Anheuser Busch Inbev NV (NYSE:BUD) is a leader in the beer brewing industry. Recently, the stock has been coming under selling pressure. BUD stock has been declining since topping out on October 10, 2017 at $126.50 a share. Today, the brewing giant is trading lower by 0.24 cents to $112.73 a share.
Traders should note that BUD stock is now trading below its important 50-day moving average. This chart formation puts the stock in a weak technical position. The next major support level for BUD stock should be around the $109.00 area. This is a very important retrace level and a place where the stock was defended in July 2017. Often, these chart factors will provide a very solid chart level for a bounce and long trade in the stock.
December 6, 2017
Costco Wholesale Corporation (NASDAQ:COST) was upgraded yesterday. Mind you, this came after a run in the stock from $154 to $188. For some reason, an analyst thought it was the right time to upgrade Costco after a huge run like this (I don’t get it). Anyways, the stock opened higher and then sold off. The reason for the reversal was because the stock slammed into a great resistance trend line (as seen in the chart below). This triggered my short (provided to Research Center members). This is a no-brainer trade in my opinion as the stock was so insanely overbought that it was a huge pullback opportunity. Add in the massive trend line and it likely is a recipe for profit.
Get the next swing trade stock in the Research Center right now, click here!